[Federal Register: April 16, 2004 (Volume 69, Number 74)]
[Notices]
[Page 20624-20629]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16ap04-61]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Centers for Genomics and Public Health
Announcement Type: New.
Funding Opportunity Number: 04143.
Catalog of Federal Domestic Assistance Number: 93.061.
Key Dates:
Letter of Intent Deadline: May 17, 2004.
Application Deadline: June 15, 2004.
Table of Contents
I. Funding Opportunity Description
I.1 Authority
I.2 Background
I.3 Purpose
I.4 Activities
II. Award Information
III. Eligibility Information
III.1 Eligible Applicants
III.2 Cost Sharing or Matching
III.3 Other
IV. Application and Submission Information
IV.1 Address to Request Application Package
IV.2 Content and Form of Submission
IV.3 Submission Dates and Times
IV.4 Intergovernmental Review of Applications
IV.5 Funding Restrictions
IV.6 Other Submission Requirements
V. Application Review Information
V.1 Criteria
V.2 Review and Selection Process
V.3 Anticipated Announcement and Award Dates
VI. Award Administration Information
VI.1 Award Notices
VI.2 Administrative and National Policy Requirements
VI.3 Reporting Requirements
VII. Agency Contacts
VIII. Other Information
I. Funding Opportunity Description
I.1 Authority
This program is authorized under section 317(k)(2) of the Public
Health Service Act (42 U.S.C. 247b(k)(2)), as amended.
I.2 Background
The wealth of information generated by the recently completed Human
Genome Project has captivated both the scientific community and the
public, and created an expectation that this knowledge will yield
future health benefits. As a result, there is an emerging need to
discover what human genome variation means for health and disease in
populations. How can research results be translated into opportunities
to improve the public's health? How can genomic information be used to
prevent, detect and treat disease? How will the health workforce
acquire the knowledge and skills needed to support the integration of
genomics into health practice and programs?
In response to these needs, the Office of Genomics and Disease
Prevention (OGDP) in collaboration with the Association of Schools of
Public Health has funded cooperative agreements with three Schools of
Public Health to establish the first Centers for Genomics and Public
Health in 2001 (http://www.cdc.gov/genomics/activities/fund2001.htm). The goal
for the initial three-year project period was to establish regional
hubs of expertise in genomics and population health by coordinating
existing institutional programs at the schools of public health and
then reaching out to engage public health programs, health care
providers and community groups. These partnerships provide a foundation
for a national network of resource centers that could develop the
capacity required to respond to future needs and opportunities related
to genomics. In the original cooperative agreement, activities were
focused in three areas: (1) Increasing the knowledge base in genomics
and public health; (2) providing technical assistance to community,
state, and regional organizations related to the integration of
genomics into public health policy and programs; and (3) developing and
providing training for the existing and future health workforce, with a
particular focus on enhancing knowledge and awareness of genomics
applications among public health workers.
I.3 Purpose
Since the initial funding of the Centers, the potential impact of
genomics on health practice and the health workforce has been widely
acknowledged. The 2002 Institute of Medicine (IOM) report entitled
``Who Will Keep the Public Healthy?'' ranked genomics as one of eight
content areas to be included in public health education programs
(http://www.iom.edu/file.asp?id=4166). Likewise, the CDC has identified
genomics as an agency priority, citing the need to assess the impact of
genomic variation on population health and to incorporate genomics into
public health programs and practice (Comments of Dr. Julie Gerberding,
CDC Director, Genomics and the Future of Public Health Symposium,
Atlanta, GA, May 5, 2003).
The purpose of Program Announcement 04143, Centers for
[[Page 20625]]
Genomics and Public Health, is to sustain development of the network of
Centers for Genomics and Public Health (Centers), and continue to
address the integration of genomics into health practice. Centers in
the network will function as regional hubs of expertise in genomics and
public health. The goal of the Centers network is to facilitate the
translation of genomic information into health policy and programs by
developing the capacity to: (1) Provide technical assistance to
community, state and regional organizations by responding to identified
needs and requests for information, assistance and training, and
supporting the integration of genomics into population health research,
policy and practice; (2) provide competency based training in genomics
and population health for the health workforce, with a particular focus
on enhancing knowledge and awareness of genomics applications among
public health workers; (3) identify opportunities to serve as a
credible and impartial provider of current information about genomics,
genomic applications and population health, particularly to the public,
policy makers and the health community; (4) participate in
collaborative processes with other Centers, CDC and external partners;
and (5) evaluate the process, achievements and impact of the Centers'
activities.
This program addresses the ``Healthy People 2010'' focus areas of:
Workforce, Prevention Research, Data and Information Systems, Public
Health Organizations and Resources.
This program is consistent with CDC's agency-wide strategic plan to
use genomic information to improve health and prevent disease across
the lifespan. Measurable outcomes of the program will be in alignment
with the performance goals for the Office of Genomics & Disease
Prevention: Development of health workforce.
I.4 Activities
Awardee activities for this program are:
(1) Provide technical assistance to community, state and regional
public health agencies (e.g., state health departments, including but
not limited to those funded under PA 03022, Genomics and
Chronic Disease Prevention: http://www.cdc.gov/genomics/activities/fund2003.htm
) and other health care practitioners (e.g., providers and
payers, community organizations) by:
(a) Serving as a source of expertise and information that has
immediate or potential relevance in the practice of medicine and public
health. For example, having the ability to provide, or provide access
to, current information related to human genome research (e.g., gene-
disease associations, gene-environment interactions), genomics and
population health (e.g., pharmacogenomics, diagnosis/treatment/
prevention of diseases of public health significance), or evidence-
based processes for interpretation of scientific developments (e.g.,
Human Genome Epidemiology {HUGE{time} reviews or systematic
evaluations of genetic tests; http://www.cdc.gov/genomics).
(b) Providing access to practical information from the current
knowledge base in formats useful to health practitioners, policy makers
and more general audiences, such as topic summaries, fact sheets and
information briefs (e.g., Public Health Perspectives: http://www.cdc.gov/genomics/info/perspective.
htm). Examples of approaches include
identifying content experts, assembling existing materials and
evaluating for accuracy and responsiveness to needs, and developing
information summaries as needed by extracting, organizing and
summarizing information.
(c) Responding to immediate needs and requests for assistance by
accessing resources through the Center, the Centers' network, and
external partners and community resources.
(d) Developing capacity to seek funding for applied research
proposals that will address identified gaps and needs.
(e) Working with community, state and national public health
partners and CDC to plan, conduct and evaluate needs assessments
related to practice or workforce development (see 2. below).
(f) Convening or participating in workgroups or processes aimed at
developing and implementing strategies for integrating genomic
information into health care, and public health research, programs and
policy (e.g., integrating family history into disease prevention
efforts, utilizing existing data sources to identify and analyze
population-based data).
(2) Provide competency-based training for health professionals,
especially the public health workforce, with a focus on practical
application of genomics knowledge in population health (http://www.cdc.gov/genomics/training/competencies
; www.nchpeg.org/nchpeg.html), by:
(a) Identifying and evaluating existing genomic training materials/
tools/modules for suitability in meeting identified needs and requests.
(b) Determining effective educational approaches (e.g., continuing
education activities, packaged training modules/materials, conferences/
workshops, web-based or distance learning) and delivering training.
(c) Calling attention to gaps in types or availability of
educational materials and training tools identified through the Centers
network and partners, and making strategic recommendations to CDC about
high priority needs for development of new materials, tools or
programs.
(3) Identify and respond to opportunities to serve as a credible
and impartial provider of current information about genomics, genomic
applications and population health to the public, policy makers, and
the health community by:
(a) Supporting proactive educational initiatives at all levels
(e.g., community based, K-12, academic, continuing education) aimed at
improving understanding of current and potential roles for genomics
information in improving health and preventing disease.
(b) Developing resources or approaches for evidence-based response
to misleading or inaccurate genomics-related information in the media
and on the Internet.
(c) Ensuring that information developed and disseminated by the
Centers network and partners provides realistic expectations about the
``value'' (e.g., efficacy, utility, acceptability, cost-effectiveness)
and public health impact of genomic applications and explains how that
value is assessed.
(4) Actively participate with CDC, the Centers network and key
external partners and collaborators (e.g., states funded to develop
genomics capacity) in a consultative process to assess major unmet
needs, identify strategies for meeting needs, and classify and
prioritize issues and topics of common interest and highest public
health importance.
(5) Develop and maintain relationships and collaborations with
public, private and academic partners that support the objectives and
activities of the network of Centers.
(6) Collaborate with CDC and other partners and investigators to
organize meetings/workshops and develop publications (e.g., articles,
peer-reviewed papers, contribution to OGDP genomics reports).
(7) Design and implement an evaluation plan that will demonstrate
and document measurable progress toward stated objectives, as well as
capture information and insights about activities, strategies (e.g.,
opportunities, successes, barriers) and impact that can be shared among
the network of Centers.
[[Page 20626]]
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine program monitoring.
CDC activities for this program are as follows:
(1) Coordinate activities, collaboration and information exchange
among the Centers, CDC, other national organizations and agencies, and
within the larger health practice community. Disseminate information
related to Center and network activities through conferences, workshops
and publications.
(2) Convene required meetings to facilitate collaboration and
information sharing, and to guide Centers in developing plans
consistent with objectives.
(3) Serve as a liaison with other Federal and outside
organizations.
(4) Help identify expertise and resources to develop specific
products/tools for which a need has been defined, but for which Centers
are not funded (e.g., development/production of products/tools
requiring multi-specialty expertise and resources).
(5) Conduct onsite visits of Centers to provide consultation and
technical support and assist Centers in meeting objectives and
requirements of the cooperative agreement.
(6) Monitor and evaluate the Center's progress toward meeting the
goals, objectives, timeline and performance evaluation.
II. Award Information
Type of Award: Cooperative Agreement.
CDC involvement in this program is listed in the CDC Activities
Section above.
Fiscal Year Funds: 2004.
Approximate Total Funding: $2.5 million.
Approximate Number of Awards: Up to five.
Approximate Average Award: $500,000 (Amount for the first 12-month
period, including both direct and indirect costs).
Floor of Award Range: $400,000.
Ceiling of Award Range: $600,000.
Anticipated Award Date: September 1, 2004.
Budget Period Length: 12 months.
Project Period Length: Four years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient as documented in required
reports and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
III.1 Eligible Applicants
Applications may be submitted by Schools of Public Health (SPH) and
other public and private nonprofit organizations, such as:
universities, colleges and research institutions.
Eligibility Criteria
Applicants must describe and document capacity and capabilities
appropriate to the program, including:
Access to, and well-defined availability of,
staff or collaborators with multidisciplinary expertise (public health
practice, epidemiology, genomics, clinical genetics and medicine,
policy, health communications and education).
Demonstrated ability to develop educational and
practice collaborations among public, private and academic partners,
with emphasis on public health and health science institutions, state
health departments and other agencies, health care organizations and
community groups.
Experience relevant to the specific objectives
and activities of the program, particularly direct involvement with
public health practice, improving population health and integrating
genomics into practice.
Expertise in needs assessment and planning and
delivering technical assistance and training to public health workers
or other health professionals.
More information on the documentation of eligibility can be found
in IV.2--Content and Form of Submission. Note that eligibility for the
initial (2001) program announcement that formed the network of Centers
for Genomics in Public Health was limited to SPH, in part to
specifically target state and community program capacity in genomics
and population health. SPH provided distinctive qualifications for
initiating this program, including health leadership and networking
capacity, relevant expertise (e.g., public health and clinical
practice, epidemiology, genomics, health education), familiarity with
public health practice and population health programs and experience
developing and delivering training to the public health workforce.
For the 2004 program announcement, institutions and organizations
listed above in III.1--Eligible Applicants (including those that are
not SPH) are invited to submit applications, but specific capacity must
be demonstrated as discussed above.
III.2 Cost Sharing or Matching
Matching funds are not required for this program.
III.3 Other
If the application is incomplete or non-responsive, or a funding
amount greater than the ceiling of the award range is requested, it
will not be entered into the review process. Applicants will be
notified that their application did not meet the submission
requirements.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
IV. Application and Submission Information
IV.1 Address To Request Application Package
To apply for this funding opportunity use application form PHS
5161. Application forms and instructions are available on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.
If applicants do not have access to the Internet, or if applicants
have difficulty accessing the forms on-line, they may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at 770-488-2700. Application forms can be mailed to
applicants.
IV.2 Content and Form of Submission
Letter of Intent (LOI): CDC requests that applicants send a LOI if
they intend to apply for this program, PA 04143 Centers for
Genomics and Public Health. The LOI is not legally binding and will not
be evaluated. It is requested from potential applicants to assist CDC
in planning for the program application review. Applicants may use the
LOI template provided in Appendix A (Appendix A can be viewed, along
with the full program announcement, on the CDC Web site at: http://www.cdc.gov/od/pgo/funding/grantmain.htm
) or provide an LOI in the
following format:
Maximum of two pages;
Single-spaced;
One inch margins;
12-point unreduced font;
8.5 by 11 inch paper;
Printed only on one side.
The LOI must contain the following information:
Program Announcement number and title;
Institution name and location;
Name, address, telephone and fax numbers, and e-
mail address of a contact person from the applicant institution;
Name of the Principal Investigator and brief
description of the applicant's professional activity focus (three to
four lines).
[[Page 20627]]
Do not include attachments. The deadline for receiving the LOI will
be May 17, 2004.
Application: The applicant must submit a project narrative with the
application forms. Each narrative must be submitted in the following
format:
Maximum number of pages: 25.
The narrative should be no more than 25 clearly numbered pages.
Federal forms, table of contents, abstract, budget, budget
justifications and appendices are not counted toward the narrative page
limit. If the narrative exceeds the page limit, only the first 25 pages
will be reviewed. Utilize the following format:
12 point unreduced font;
8.5 by 11 inch paper, printed only on one side;
Double spaced;
One inch margins;
Held together only by rubber bands or metal
clips.
The narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed:
Abstract--A one-page, single-spaced abstract of
the narrative with a heading that includes the title, organization,
name and address of the project director, telephone and fax numbers and
e-mail address.
Table of Contents.
Background--(1) Provide background that
illustrates understanding of the translation continuum from human
genome research to integration of genomics information into health
practice, particularly the strategies for integrating knowledge into
programs and workforce capacity that form the basis of the program. (2)
Justify the need(s) for the proposed activities, and describe the
relevance of expected outcomes to the Purpose of the Announcement.
Relevant Resources and Experience--(1) Describe
available facilities and infrastructure, technological capacity and
other resources, and document institutional commitment to support of
the Center; (2) Describe and document (e.g., publications, products,
presentations) prior or current experience, such as related projects
and collaborations, or genomics and population health research
capacity, that is relevant to the purpose and proposed activities of
this cooperative agreement; (3) Address specific capacity and
capability criteria as described in the eligibility requirements
(sections III.1 and III.3).
Proposed Staffing--(1) Provide a biographical
sketch for the Principal Investigator/Program Director and all key
personnel. (2) Provide a description of all project staff, regardless
of their funding source, that includes: title, qualifications,
experience, responsibilities, minimum percentage of time to be devoted
to the project and the proportion of the salary to be paid by the
cooperative agreement. (3) Provide a timetable for the recruitment and
hiring of proposed additional qualified staff and an organizational
chart that illustrates the staffing plan.
Work Plan--Applicants should provide a detailed
work plan that describes their current ability to address each of the
elements in the ``Recipient Activities'' section of this announcement,
as well as their specific plans for developing additional capacity over
the project period. Applicants are also encouraged to propose unique
initiatives/approaches based on their interests and expertise that are
relevant to and/or build upon one or more of these activities. The Work
Plan should: (1) Provide specific, measurable and time-framed
objectives for proposed responses to the ``Recipient Activities.'' (2)
Describe proposed methods and approaches by which the objectives will
be achieved. (3) Present a timeline for activities and objectives over
the project period. (4) Provide a description of the involvement of
other entities in the proposed project, including academic, private and
public partners (particularly state and local health departments,
health organizations and community groups), with a clear statement of
roles and commitment of time that are reflected in attached letters of
support. Be sure to distinguish activities and outcomes of joint and/or
overlapping projects supported through other sources. (5) Describe
proposed performance measures, products or other quantifiable outcomes
for each activity and objective.
Evaluation--Describe plans for establishing a
four-year Center-level evaluation protocol. Include evaluation goals,
resources and infrastructure to develop/support the plan: how project
partners and communities served will provide input in plan development,
an implementation timeline and a visual representation that depicts
specific activities and outcomes (e.g., flow diagram, table, logic
model: http://www.wkkf.org). The evaluation protocol should be capable
of documenting measurable progress toward specific objectives,
activities and projected outcomes outlined in the work plan, as well as
demonstrating the degree to which strategies and programs were
delivered as intended, their effectiveness in achieving desired
results, successful collaborations with public health and other
partners, lessons learned and how evaluation results will be used to
improve the overall impact of the Centers.
Budget--Provide a detailed budget for year one
of the cooperative agreement and budget projections for subsequent
years. Include travel for two persons to attend an annual two-day
meeting in Atlanta.
Budget Justification--Provide a narrative that
includes justification for all requested costs, including personnel
(i.e., name, position title, annual salary, percentage of time and
effort, amount requested) and consultants (as above plus period of
performance and scope of work).
Additional information should be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes:
Curriculum vitaes/resumes/biosketches;
Letters of support (required);
Organizational charts, evaluation models.
Questions that arise during the application process should be
clearly stated and emailed to Dr. Myers at the Office of Genomics and
Disease Prevention (MFMyers@cdc.gov). Responses will be generated by
program staff and made available for all applicants to view. The
questions and answers will be posted at least weekly at: http://www.cdc.gov/genomics/RFA2004questions.htm.
Applicants may submit their questions in
this format only.
Applicants are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm
.
If the application form does not have a DUNS number field, the
applicant should write the DUNS number at the top of the first page of
the application, and/or include the DUNS number in the application
cover letter.
Additional requirements that may require the applicant to submit
additional documentation with the application are listed in section
``VI.2. Administrative and National Policy Requirements.''
[[Page 20628]]
IV.3 Submission Dates and Times
LOI Deadline Date: May 17, 2004.
Application Deadline Date: June 15, 2004.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. eastern time on the deadline
date. If the application is sent by the United States Postal Service or
commercial delivery service, the applicant must ensure that the carrier
will be able to guarantee delivery of the application by the closing
date and time. If CDC receives the application after closing due to:
(1) Carrier error, when the carrier accepted the package with a
guarantee for delivery by the closing date and time, or (2) significant
weather delays or natural disasters, the applicant will be given the
opportunity to submit documentation of the carrier's guarantee. If the
documentation verifies a carrier problem, CDC will consider the
application as having been received by the deadline.
This announcement is the definitive guide on application submission
address and deadline. It supersedes information provided in the
application instructions. If the application does not meet the deadline
above, it will not be eligible for review, and will be discarded. The
applicants will be notified that their application did not meet the
submission requirements.
CDC will not notify the applicant upon receipt of the application.
If the applicant has a question about the receipt of the application,
first contact the courier. If the applicant still has a question,
contact the PGO-TIM staff at: 770-488-2700. Before calling, please wait
two to three days after the application deadline. This will allow time
for applications to be processed and logged.
IV.4 Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV.5 Funding Restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Use of Funds--Cooperative agreement funds may
not be used to support the provision of direct patient care, for
facility or capital outlay, or to conduct research involving human
subjects.
Awards will not allow reimbursement of pre-award
costs.
Funds should not be allocated to develop/produce
new training products/tools, such as CD-ROMs or on-line training. See
Sections on Recipient Activities (3) and I.4, (2) c.
If indirect costs are requested in the budget, a copy of all
indirect cost rate agreements must be included. If the indirect cost
rate is a provisional rate, the agreement should be less than 12 months
of age.
Guidance for completing the budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
IV.6 Other Submission Requirements
LOI Submission Address: Submit your LOI by express mail, delivery
service, fax, or e-mail to: Melanie F. Myers, Ph.D., Office of Genomics
and Disease Prevention, Office of the Director, Centers for Disease
Control and Prevention, 1600 Clifton Road, NE., Mail Stop E-82,
Atlanta, GA 30333, fax: 404-498-1444, e-mail: MFMyers@cdc.gov.
Application Submission Address: Submit the original and two hard
copies of your application by mail or express delivery service to:
Technical Information Management--PA 04143, CDC Procurement
and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.
V. Application Review Information
V.1 Criteria
Applicants are required to provide measures of effectiveness that
relate to the goal stated in the ``Purpose'' section (I.3) of this
announcement and will demonstrate the accomplishment of the various
identified objectives and activities of the cooperative agreement.
Measures must be objective and quantitative, and must measure the
intended outcome(s) (as described in the Work Plan and Evaluation Plan,
section IV.2). These measures of effectiveness must be submitted with
the application and will be one element in the evaluation of the full
proposal described below.
Note that the criteria below are listed in descending order by
weight. Applicants do not need to utilize this weighted order in
preparing the narrative (see IV.2 for guidance on content).
Applications will be evaluated against the following criteria:
Work Plan (25 Points):
Does the applicant adequately describe a work plan for achieving
the proposed objectives?
Does the applicant provide specific, measurable and time-framed
objectives for each of the recipient activities?
Is there a realistic timeline and adequate allocation of resources
for major activities?
Does the applicant adequately support the proposed approaches and
methodology to carry out project activities?
Are projected products and outcomes clearly defined?
Does the applicant adequately describe relationships with public
health, health care and academic partners, including defined roles and
levels of commitment to this proposal, and methods for establishing and
maintaining these relationships?
Were all appropriate letters of support provided?
Relevant Experience (20 Points):
Does the demonstrated experience of the applicant team and partners
support their ability to accomplish the proposed objectives and
activities?
Does the applicant demonstrate their ability and willingness to
successfully participate in collaborative activities?
How well does the applicant describe and document the principal
investigator's experience and expertise, including project oversight,
collaboration(s) with the health practice community and a track record
of producing results and reports for publication?
Staffing (20 Points):
Does the applicant provide a staffing plan that includes defined
roles, relevant expertise and experience, percentage effort of key
personnel and timetable for any planned recruitment?
Does the applicant provide an organizational chart that illustrates
internal and external relationships?
How well do the organizational chart and staffing plan support the
proposed objectives and activities?
Have the principal investigator and other key personnel obligated a
sufficient amount of time to support the proposed roles?
Is the PI's authority and responsibility for carrying out the
proposed project clearly defined?
Resources (15 Points):
How well does the applicant describe the institutional commitment
to the development of the Center (e.g., facilities, technological
capacity, other resources)?
Is the commitment and allocation of fiscal and professional
resources adequate to support the proposal?
How well does the applicant describe and document commitment of
academic, public and private partners and collaborators?
Evaluation Plan (10 Points):
Does the applicant provide a comprehensive four-year evaluation
[[Page 20629]]
plan, including clearly stated objectives?
Does the evaluation plan support measurement of progress toward the
achievement of time-framed objectives and planned activities?
Does the evaluation plan support the ability to gather information
about the Center development process?
Background (10 Points):
Does the applicant display an understanding of the genome research
to practice continuum and how proposed activities will facilitate
translation of knowledge to practice?
Does the applicant demonstrate understanding of public health and
health practice, and the need to incorporate genomics capacity into
population health programs?
Does the applicant clearly explain the relevance of the proposed
recipient activities (section I.4) to the Purpose of the Announcement
(I.3)?
Budget (Reviewed, but not Scored):
Is the budget submitted by the applicant detailed, clear, justified
and consistent with proposed program activities?
V.2 Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by OGDP.
Incomplete applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above.
In addition, the following factors may affect the funding decision:
Maintenance of geographic diversity.
V.3 Anticipated Announcement and Award Dates
September 1, 2004.
VI. Award Administration Information
VI.1 Award Notices
Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2 Administrative and National Policy Requirements 45 CFR part 74 and
part 92.
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.accessxgpo.gov/nara/cfr/cfr-table-search.html
The following additional requirements apply to this project:
AR-8 Public Health System Reporting Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010;
AR-12 Lobbying Restrictions;
AR-14 Accounting System Requirements;
AR-15 Proof of Non-profit Status;
AR-20 Conference Support;
AR-24 Health Insurance Portability and
Accountability Act Requirements.
VI.3 Reporting Requirements
The applicant must provide CDC with an original, plus two hard
copies, of the following reports:
(1) Annual interim progress report (no less than 90 days before the
end of the budget period). The progress report will serve as your non-
competing continuation application, and must contain the following
elements:
a. Current Budget Period Activities Objectives;
b. Current Budget Period Financial Progress;
c. New Budget Period Program Proposed Activity Objectives;
d. Budget;
e. Additional Requested Information;
f. Measures of Effectiveness.
(2) Financial status report, (no more than 90 days after the end of
the budget period) and semi-annual progress report by March 15 of each
funding year.
(3) Final financial and performance reports (no more than 90 days
after the end of the project period).
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
Technical questions that arise during the application process
should be clearly stated and e-mailed to Dr. Myers at the Office of
Genomics and Disease Prevention (MFMyers@cdc.gov). Responses will be
generated by program staff and made available for all applicants to
view. The questions and answers will be posted at least weekly at:
http://www.cdc.gov/genomics/RFA2004questions.htm. Applicants may submit their
questions in this format only.
For general questions about this announcement, contact: Technical
Information Management Section, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341, telephone number: 770-488-2700.
For grants management, or budget assistance, contact: Mattie
Jackson, Grants Management Specialist, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341, telephone number: 770-
488-2696, e-mail: mij3@cdc.gov.
For program technical assistance, contact: Melanie F. Myers, Ph.D.,
Office of Genomics and Disease Prevention, Office of the Director,
Centers for Disease Control and Prevention, 1600 Clifton Road, NE.,
Mail Stop E-82, Atlanta, GA 30333, e-mail: MFMyers@cdc.gov.
Dated: April 9, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-8637 Filed 4-15-04; 8:45 am]
BILLING CODE 4163-18-P